The Readout Loud

350: Pharma tariffs, and a 'sunshine day' for biotech stocks

13 snips
Apr 24, 2025
Ask episode
AI Snips
Chapters
Transcript
Episode notes
INSIGHT

Biotech Stocks Showing Recovery Signs

  • Biotech stocks have shown initial signs of recovery after a prolonged slump this year.
  • Positive FDA messaging on drug approvals helped boost investor confidence and stock prices.
INSIGHT

Tariff Uncertainty Clouds Pharma Outlook

  • Uncertainty around US tariffs on pharmaceutical imports remains high and rhetoric shifts frequently.
  • Biotech confidence depends on how tariffs will impact supply chains and overall market dynamics.
ANECDOTE

Sam Waksal Lawsuit and Allegations

  • Sam Waksal was sued over allegations including smuggling an unapproved veterinary medicine for use on a severely ill child.
  • Allegations include reckless conduct and financial mismanagement linked to company bankruptcy.
Get the Snipd Podcast app to discover more snips from this episode
Get the app